A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder. [electronic resource]
Producer: 20040527Description: 553-5 p. digitalISSN:- 0006-3223
- Adult
- Aged
- Analysis of Variance
- Antipsychotic Agents -- administration & dosage
- Benzodiazepines -- administration & dosage
- Double-Blind Method
- Drug Resistance
- Drug Therapy, Combination
- Female
- Fluoxetine -- administration & dosage
- Humans
- Male
- Middle Aged
- Obsessive-Compulsive Disorder -- drug therapy
- Olanzapine
- Prospective Studies
- Selective Serotonin Reuptake Inhibitors -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.